Understanding how CRISPR systems in bacteria and archaea respond to invading RNA
CRISPR RNA-guided recognition of invading RNA activates a multipronged cell death response
['FUNDING_FELLOWSHIP'] · MONTANA STATE UNIVERSITY - BOZEMAN · NIH-11007178
This study is looking at how a special immune system in bacteria and archaea uses CRISPR to recognize and fight off invading RNA, which could help us understand how these tiny organisms protect themselves from viruses and other genetic dangers.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MONTANA STATE UNIVERSITY - BOZEMAN (nih funded) |
| Locations | 1 site (BOZEMAN, UNITED STATES) |
| Trial ID | NIH-11007178 on ClinicalTrials.gov |
What this research studies
This research investigates how CRISPR systems, which are part of the immune response in bacteria and archaea, recognize and respond to invading RNA. By focusing on a specific type of CRISPR system that targets RNA instead of DNA, the study aims to uncover the mechanisms behind this immune response. The researchers will analyze the structure and function of these systems, particularly how they activate a cell death response when they detect foreign RNA. This could lead to new insights into how these organisms defend themselves against viruses and other genetic threats.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in the mechanisms of immune responses, particularly those with conditions related to viral infections.
Not a fit: Patients with conditions unrelated to viral infections or those not interested in the biological mechanisms of immune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses, potentially leading to new therapeutic strategies against viral infections.
How similar studies have performed: Previous research has shown promise in understanding CRISPR systems, but this specific approach focusing on RNA targeting is relatively novel.
Where this research is happening
BOZEMAN, UNITED STATES
- MONTANA STATE UNIVERSITY - BOZEMAN — BOZEMAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BURMAN, NATHANIEL — MONTANA STATE UNIVERSITY - BOZEMAN
- Study coordinator: BURMAN, NATHANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.